Concourse Financial Group Securities, Inc. Mereo Biopharma Group PLC Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$3.45 - $4.87 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$2.58 - $4.25 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$2.3 - $4.05 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$1.19 - $2.42 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$1.15 - $1.67 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$1.15 - $1.67 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$0.79 - $1.43 $0 - $0
Q1 2023 May 15, 2023	BUY	$0.71 - $1.22 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$0.5 - $1.01 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$0.82 - $1.73 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$0.33 - $1.69 $0 - $0
Q1 2022 May 09, 2022	BUY	$1.04 - $1.7 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$1.51 - $2.59 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$2.2 - $3.17 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$2.94 - $4.08 $0 - $0
Q1 2021 May 13, 2021	BUY	$2.6 - $4.43 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$1.95 - $3.6 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$2.55 - $3.29 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$1.0 - $3.4 $0 - $0
Q1 2020 May 13, 2020	BUY	$0.8 - $3.21 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$1.1 - $3.7 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$2.22 - $4.14 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$2.52 - $6.5 $0 - $0

Others Institutions Holding MREO

# of Institutions

Shares Held

107M

Call Options Held

209K

Put Options Held

479K

Rubric Capital Management LP New York, NY

15.3M
Shares

$52 Million
1.75% of portfolio
Janus Henderson Group PLC London, X0

12.3M
Shares

$42 Million
0.03% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

9.72M
Shares

$33 Million
0.07% of portfolio
Rock Springs Capital Management LP Baltimore, MD

9.53M
Shares

$32.4 Million
1.33% of portfolio
Mangrove Partners New York, NY

8.73M
Shares

$29.7 Million
4.66% of portfolio

View Full List

About Mereo Biopharma Group plc

Ticker MREO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,986,000
Market Cap $425M
Description
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...

More about MREO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account